NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III Sells 31,798 Shares

NeueHealth, Inc. (NYSE:NEUE - Get Free Report) CEO George Lawrence Mikan III sold 31,798 shares of the company's stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $7.33, for a total transaction of $233,079.34. Following the completion of the transaction, the chief executive officer now directly owns 146,539 shares in the company, valued at $1,074,130.87. The trade was a 17.83 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

George Lawrence Mikan III also recently made the following trade(s):

• On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The shares were sold at an average price of $4.18, for a total transaction of $70,236.54.

NeueHealth Stock Performance

Shares of NYSE NEUE traded up $0.05 during trading on Wednesday, reaching $7.45. The stock had a trading volume of 38,124 shares, compared to its average volume of 70,685. The business's 50-day moving average price is $5.47 and its 200-day moving average price is $5.38. NeueHealth, Inc. has a fifty-two week low of $3.79 and a fifty-two week high of $16.59. The company has a market cap of $61.72 million, a P/E ratio of -0.15 and a beta of 0.57.

Hedge Funds Weigh In On NeueHealth

Institutional investors have recently bought and sold shares of the company. Partners Group Holding AG acquired a new stake in shares of NeueHealth during the third quarter worth about $463,000. Deer Management Co. LLC purchased a new stake in NeueHealth during the 2nd quarter worth approximately $5,436,000. NEA Management Company LLC acquired a new stake in NeueHealth during the 2nd quarter worth approximately $14,834,000. Finally, Renaissance Technologies LLC purchased a new position in NeueHealth in the 2nd quarter valued at approximately $312,000. 63.88% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Royal Bank of Canada lowered their price objective on shares of NeueHealth from $8.00 to $7.00 and set a "sector perform" rating for the company in a research report on Monday, December 9th.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.